Inaktiver Wert

Andere Sprachen Celldex Therapeutics, Inc. Nasdaq

Aktien

US15117B1035

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

Celldex: Q1 Earnings Snapshot	06.05.
Earnings Flash (CLDX) CELLDEX THERAPEUTICS Posts Q1 Revenue $156,000	06.05.
Celldex Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06.05.
Celldex Reports First Quarter 2024 Financial Results and Provides Corporate Update	06.05.
Sector Update: Health Care Stocks Mixed Wednesday Afternoon	17.04.
Celldex Therapeutics Says Patient Enrollment Completed in Chronic Inducible Urticaria Treatment Study; Shares Rise	17.04.
Celldex Therapeutics : Corporate Presentation	17.04.
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria	17.04.
Celldex Therapeutics, Inc. Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria	17.04.
Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference	08.03.
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares	06.03.
Celldex Therapeutics to Present at TD Cowen's 44th Annual Health Care Conference	06.03.
Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference	05.03.
Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares	05.03.
Celldex Therapeutics Prices $400.4 Million Common Stock Offering	01.03.
Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock	01.03.
Celldex Therapeutics Proposes $250 Million Underwritten Common Stock Offering	28.02.
Celldex Therapeutics Announces Proposed Public Offering of Common Stock	28.02.
Sector Update: Health Care Stocks Weaker Monday Afternoon	26.02.
Celldex Therapeutics Shares Rise After Q4 Revenue Tops Estimates	26.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Celldex Therapeutics, Inc. Nasdaq

Aktien

US15117B1035

Andere Sprachen

Filter